Impact of Foods on Bile Acids, Metabolites, and Inflammation
NCT ID: NCT05245357
Last Updated: 2023-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2022-02-24
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. determine the impact of acute lentil ingestion on serum postprandial bile acid responses and composition in a human cohort with obesity, and
2. determine the impact of daily lentil consumption for 12 weeks on serum fasting and postprandial bile acid concentrations and composition in an overweight or obese cohort with elevated postprandial triglycerides.
This proposal is being submitted in response to the American Pulse Association commodity board sponsored topic of investigating the impact pulse crop consumption on health.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bile Acids As Determinants of Postprandial Metabolism
NCT06758453
The Effect of a Probiotic on Hepatic Steatosis
NCT00099723
Regulation of Human Intestinal Bile Acid Transport in Health and Disease
NCT00018681
Regulation of Sterol Homeostasis
NCT00018720
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The approach for Objective 2 will leverage banked samples from a highly synergistic ongoing clinical trial comparing 12 weeks of daily lentil consumption to control. This study utilizes a randomized, parallel research design to compare the impact of ingesting 140 g of lentils per day to 0 g per day for 12 weeks on serum triglyceride and inflammation responses to a high-fat meal. High fat meals induce the largest serum bile acid responses so the current proposal augments this study by adding assessment of the impact of prolonged lentil consumption on the appearance of bile acids in the systemic circulation under fasting and postprandial conditions. In contrast to Objective 1, which focuses on the acute impact of incorporating lentils into a meal, Objective 2 will measure the impact of adaptations to lentil ingestion that improve enterohepatic function. These changes may be facilitated by changes to the composition of the gut microbiome, enhanced bile acid excretion, or other mechanisms independent of having lentils in the challenge meal. Data from the ongoing trial will be analyzed to determine whether lentils induced changes in the composition of the gut microbiome. This proposal will analyze whether lentil consumption increases excretion of bile acids by analyzing bile acid composition of stool samples collected before and after lentil supplementation. In sum, adding analysis of serum and stool bile acids from samples collected and banked in an ongoing clinical trial, will allow the determination of whether lentil consumption over time improves enterohepatic health in a way that reduces appearance of bile acids in serum and or increases excretion of bile acids.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lentil, then Control
Participants first received a meal with 140 g of lentils in the morning. After a washout period of at least 7 days, they then received a meal with 0 g of lentils in the morning.
Lentil
Participants in the lentil arm of the study will consume a meal containing 140 g of lentils for breakfast one morning.
Control
Participants in the control arm of the study will consume a meal containing 0 g of lentils for breakfast one morning.
Control, then Lentil
Participants first received a meal with 0 g of lentils in the morning. After a washout period of at least 7 days, they then received a meal with 140 g of lentils in the morning.
Lentil
Participants in the lentil arm of the study will consume a meal containing 140 g of lentils for breakfast one morning.
Control
Participants in the control arm of the study will consume a meal containing 0 g of lentils for breakfast one morning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lentil
Participants in the lentil arm of the study will consume a meal containing 140 g of lentils for breakfast one morning.
Control
Participants in the control arm of the study will consume a meal containing 0 g of lentils for breakfast one morning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index greater than 27 kg/m\^2
Exclusion Criteria
* a gallbladder condition or have had the gallbladder removed
* allergy to wheat, dairy, or legumes
* pregnant or lactating
* have been on a ketogenic or paleo diet in the past 6 weeks
* have been on antibiotics in the past 90 days
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montana State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary P Miles, PhD
Role: PRINCIPAL_INVESTIGATOR
Montana State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nutrition Research Laboratory
Bozeman, Montana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFRI Grant 2021-67028-34103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.